Sansure Biotech Inc. (688289.SH) Obtains Medical Device Registration Certificates for Four Products
Stock News
Dec 16
Sansure Biotech Inc. (688289.SH) announced that the company has recently received Medical Device Registration Certificates issued by the National Medical Products Administration for four of its products. The products include: Escherichia coli, Acinetobacter baumannii, and Stenotrophomonas maltophilia Nucleic Acid Detection Kit (Fluorescent PCR Method); Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis Nucleic Acid Detection Kit (Fluorescent PCR Method); Human CYP3A5 Gene Polymorphism Nucleic Acid Detection Kit (PCR-Fluorescent Probe Method); and EB Virus Nucleic Acid Detection Kit (Fluorescent PCR Method).
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.